Delivery Order SPE2DR25D1017-SPE2DR26F9CBH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,981.42 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injectors. The contract, issued on November 20, 2025, with an ultimate completion date of December 12, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order under a competitive procurement process, demonstrating its capability to...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on November 24, 2025, with an ultimate completion date of December 16, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters and distribution facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $18,496.02 delivery order to AmerisourceBergen Drug Corp for BENLYSTA 200 mg/mL auto-injector on August 7, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency has awarded a delivery order valued at $9,745.98 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector units. The contract, issued on December 22, 2025, with an ultimate completion date of January 14, 2026, represents a firm fixed-price delivery under a competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a $6,497.32 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Benlysta 200 mg/mL auto-injectors. This non-set-aside, competitively awarded contract is scheduled for completion by December 31, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $9,745.98 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed-price delivery order with performance to be completed by January 8, 2026, at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract award represents a non-set-aside, competitively awarded transaction under the company's existing federal contract vehicle with the agency. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on December 5, 2025, with a completion date of December 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $9,248.01 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on August 28, 2025, with completion expected by September 19, 2025. This firm fixed-price delivery order is unclassified as a set-aside contract and represents a competitive award to the pharmaceutical distributor. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on December 9, 2025, with completion expected by December 31, 2025. This competitively awarded, firm fixed-price delivery order requires performance at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $12,994.64 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector on December 8, 2025, with completion targeted for December 30, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government, leveraging the company's extensive capabilities as a...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9CBHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injectors on December 26, 2025, with an ultimate completion date of January 20, 2026. This non-competitive delivery order represents a firm fixed-price transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and enables the company to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs globally. Benlysta, a biologic medication used in the treatment of systemic lupus erythematosus, represents one of the specialized pharmaceutical products the contractor delivers through this vehicle to support defense healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 12/25/25 |